Company intelligence / Profile preview

Fishman Group

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

The Fishman Group, also known as Fishman Holdings, was a prominent Israeli investment conglomerate with a significant focus on the life sciences and biotechnology sectors. Through its dedicated arm, Fishman Biotech, the group served as a major venture capital driver in Israel, providing seed to pre-IPO financing and management support for numerous healthcare startups. Its portfolio included notable companies such as Mediwound, PolyPid, and Galmed Pharmaceuticals, which focused on advanced wound care, drug delivery, and liver diseases. While the group faced a high-profile liquidation process starting around 2016 due to financial difficulties of its founder, Eliezer Fishman, its impact on the Israeli biotech ecosystem remains significant through the continued operation of its former portfolio companies.

Industry: Investors

Beyond the preview

Go deeper on Fishman Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fishman Group.

Explore the full profile